Janardan Pandey to HIV Infections
This is a "connection" page, showing publications Janardan Pandey has written about HIV Infections.
Connection Strength
1.432
-
HIV-1 Control and Immunoglobulin Genes. J Infect Dis. 2018 03 13; 217(7):1170.
Score: 0.340
-
Genetic variants of Fc? (GM allotypes) and the Fc-mediated effector functions in HIV-1 controllers. J Virol. 2014 Jun; 88(12):7117.
Score: 0.261
-
Immunoglobulin genes and the acquisition of HIV infection in a randomized trial of recombinant adenovirus HIV vaccine. Virology. 2013 Jun 20; 441(1):70-4.
Score: 0.241
-
Epistatic interactions between Fc (GM) and Fc?R genes and the host control of human immunodeficiency virus replication. Hum Immunol. 2012 Mar; 73(3):263-6.
Score: 0.220
-
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial. Nat Med. 2022 05; 28(5):1022-1030.
Score: 0.113
-
Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial. Lancet HIV. 2019 10; 6(10):e667-e679.
Score: 0.094
-
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection. Sci Transl Med. 2015 12 23; 7(319):319ra206.
Score: 0.073
-
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults. Clin Exp Immunol. 2015 Dec; 182(3):289-301.
Score: 0.072
-
IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J Infect Dis. 1996 Jun; 173(6):1347-53.
Score: 0.019